Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial

The informed consent (IC) of subjects participating in experimental studies is the mainstay to comply with the ethical principle of autonomy to ensure that the participation is voluntary. This experience was performed within the context of a single-center randomized clinical trial in elective prosth...

Full description

Bibliographic Details
Main Authors: Maria López-Parra, Francesc Zamora-Carmona, Mònica Sianes-Gallén, Esmeralda López-González, Dolors Gil-Rey, Helena Costa-Ventura, Miriam Borrás-Sánchez, Gemma Rayo-Posadas, Marta Arizu-Puigvert, Roser Vives-Vilagut
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/10/6/1036
_version_ 1797486970744602624
author Maria López-Parra
Francesc Zamora-Carmona
Mònica Sianes-Gallén
Esmeralda López-González
Dolors Gil-Rey
Helena Costa-Ventura
Miriam Borrás-Sánchez
Gemma Rayo-Posadas
Marta Arizu-Puigvert
Roser Vives-Vilagut
author_facet Maria López-Parra
Francesc Zamora-Carmona
Mònica Sianes-Gallén
Esmeralda López-González
Dolors Gil-Rey
Helena Costa-Ventura
Miriam Borrás-Sánchez
Gemma Rayo-Posadas
Marta Arizu-Puigvert
Roser Vives-Vilagut
author_sort Maria López-Parra
collection DOAJ
description The informed consent (IC) of subjects participating in experimental studies is the mainstay to comply with the ethical principle of autonomy to ensure that the participation is voluntary. This experience was performed within the context of a single-center randomized clinical trial in elective prosthetic surgery. Obtaining IC in clinical trials is not without difficulties, and especially in the case of vulnerable populations it can be very challenging. This work aimed to identify the difficulties during the IC process for a clinical trial in subjects older than 65 years old and quantify and describe the use of IC in front of a witness. Methods: This is a mixed methodology study with a qualitative part (focus group with 4 nurses involved in the inclusion of subjects) and a quantitative part describing the characteristics of patients who signed IC forms. Results: The main difficulties identified are related to comprehension, sensory impairments, education level, and time. IC in front of witnesses was used in 20 patients out of 508. Conclusions: The participation of subjects older than 65 years old in clinical trials requires an adaptation of the process. The use of IC in front of a witness should always be considered in studies including elderly subjects.
first_indexed 2024-03-09T23:40:57Z
format Article
id doaj.art-74efc821bd724587abd6b2c1e05a3e5c
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-03-09T23:40:57Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-74efc821bd724587abd6b2c1e05a3e5c2023-11-23T16:51:55ZengMDPI AGHealthcare2227-90322022-06-01106103610.3390/healthcare10061036Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled TrialMaria López-Parra0Francesc Zamora-Carmona1Mònica Sianes-Gallén2Esmeralda López-González3Dolors Gil-Rey4Helena Costa-Ventura5Miriam Borrás-Sánchez6Gemma Rayo-Posadas7Marta Arizu-Puigvert8Roser Vives-Vilagut9Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainInstitut Català de la Salut, North Metropolitan, 08924 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainParc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, Sabadell, 08206 Barcelona, SpainDepartament de Farmacologia, de Terapèutica i de Toxicologia, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, SpainThe informed consent (IC) of subjects participating in experimental studies is the mainstay to comply with the ethical principle of autonomy to ensure that the participation is voluntary. This experience was performed within the context of a single-center randomized clinical trial in elective prosthetic surgery. Obtaining IC in clinical trials is not without difficulties, and especially in the case of vulnerable populations it can be very challenging. This work aimed to identify the difficulties during the IC process for a clinical trial in subjects older than 65 years old and quantify and describe the use of IC in front of a witness. Methods: This is a mixed methodology study with a qualitative part (focus group with 4 nurses involved in the inclusion of subjects) and a quantitative part describing the characteristics of patients who signed IC forms. Results: The main difficulties identified are related to comprehension, sensory impairments, education level, and time. IC in front of witnesses was used in 20 patients out of 508. Conclusions: The participation of subjects older than 65 years old in clinical trials requires an adaptation of the process. The use of IC in front of a witness should always be considered in studies including elderly subjects.https://www.mdpi.com/2227-9032/10/6/1036agedinformed consent formnursesrandomized controlled trial
spellingShingle Maria López-Parra
Francesc Zamora-Carmona
Mònica Sianes-Gallén
Esmeralda López-González
Dolors Gil-Rey
Helena Costa-Ventura
Miriam Borrás-Sánchez
Gemma Rayo-Posadas
Marta Arizu-Puigvert
Roser Vives-Vilagut
Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
Healthcare
aged
informed consent form
nurses
randomized controlled trial
title Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
title_full Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
title_fullStr Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
title_full_unstemmed Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
title_short Patient Information and Informed Consent for Research in the Elderly: Lessons Learned from a Randomized Controlled Trial
title_sort patient information and informed consent for research in the elderly lessons learned from a randomized controlled trial
topic aged
informed consent form
nurses
randomized controlled trial
url https://www.mdpi.com/2227-9032/10/6/1036
work_keys_str_mv AT marialopezparra patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT francesczamoracarmona patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT monicasianesgallen patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT esmeraldalopezgonzalez patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT dolorsgilrey patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT helenacostaventura patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT miriamborrassanchez patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT gemmarayoposadas patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT martaarizupuigvert patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial
AT roservivesvilagut patientinformationandinformedconsentforresearchintheelderlylessonslearnedfromarandomizedcontrolledtrial